We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 1BIIB market cap is 20.63B. The company's latest EPS is USD 7.9681 and P/E is 18.70.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 14.38B | 13.44B | 10.98B | 10.17B | 9.84B |
Operating Income | 7.03B | 4.37B | 3.04B | 2.76B | 1.61B |
Net Income | 5.89B | 4B | 1.81B | 3.05B | 1.16B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 27.23B | 24.62B | 23.88B | 24.55B | 26.84B |
Total Liabilities | 13.9B | 13.93B | 12.92B | 11.17B | 12.05B |
Total Equity | 13.34B | 10.69B | 10.96B | 13.39B | 14.8B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 7.08B | 4.23B | 3.64B | 1.38B | 1.55B |
Investing | 470.5M | -608.6M | -563.7M | 1.58B | -4.1B |
Financing | -5.86B | -5.27B | -2.09B | -1.75B | 149.3M |
Market Cap | 20.63B |
Price to Earnings Ratio | 18.70 |
Price to Sales Ratio | 2.21 |
Price to Cash Ratio | 20.68 |
Price to Book Ratio | 1.47 |
Dividend Yield | - |
Shares Outstanding | 145.72M |
Average Volume (1 week) | 16 |
Average Volume (1 Month) | 26 |
52 Week Change | -39.56% |
52 Week High | 244.60 |
52 Week Low | 141.45 |
Spread (Intraday) | 0.75 (0.53%) |
Company Name | Biogen Inc |
Address |
3411 silverside road tatnall wilmington, delaware 19810 |
Website | https://www.biogen.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions